Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2, 2007. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically concerning the US Retirement Savings Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific transaction event rather than general financial performance.
Material Changes
The filing details a re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan, which is notionally held in GSK Ordinary Share ADRs. On June 29, 2007, there was an increase in the notional allocation of Ordinary Share ADRs at a price of $52.37 per share for the following individuals:
- Mrs C Bruck Slaoui
- Dr R G Greig
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the specific transaction notification.
Key Facts for Investor Verification
- Transaction Date: June 29, 2007
- Transaction Type: Increase in notional allocation of Ordinary Share ADRs
- Price per Share: $52.37
- Involved Parties: Mrs C Bruck Slaoui and Dr R G Greig
- Plan Context: US Retirement Savings Plan